Nifuroksazyd Aflofarm (Nifuroxazide)

Nifuroxazide, the active ingredient in Nifuroksazyd Aflofarm, is a nitrofuran antibacterial presented as an oral formulation for gastrointestinal use. It is employed to manage acute infectious diarrhoea and other intestinal infections caused by susceptible bacteria, particularly in adults and children who can tolerate oral therapy.

GNH USA supplies Nifuroksazyd Aflofarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nifuroxazide acts within the intestinal lumen to treat bacterial diarrhoeal conditions. - Acute infectious diarrhea: shortens the duration and lessens the severity of symptoms caused by susceptible bacterial pathogens. - Intestinal infections caused by susceptible bacteria: reduces bacterial load and alleviates associated abdominal discomfort. - Travel‑related diarrhoea: provides symptomatic relief and bacterial control for travellers exposed to enteric pathogens.

Adverse reactions are generally mild and limited to the gastrointestinal tract, but rare systemic events have been reported.

Common Side Effects: - Nausea: mild to moderate discomfort after ingestion. - Abdominal cramps: transient colicky pain. - Flatulence: increased intestinal gas. - Mild headache: occasional tension‑type headache. - Skin rash: limited erythematous eruption.

Serious or Rare Side Effects: - Severe allergic reaction: anaphylaxis or angioedema requiring immediate medical attention. - Hepatotoxicity: elevated liver enzymes indicating liver stress. - Hematologic abnormalities: rare cases of neutropenia or thrombocytopenia. - Persistent diarrhoea: worsening of symptoms despite therapy. - Clostridioides difficile infection: overgrowth due to alteration of gut flora.

Before using Nifuroksazyd Aflofarm, consider the following safety measures. - Allergy assessment: avoid if known hypersensitivity to nitrofurans exists. - Age limitation: use with caution in children under two years of age. - Renal impairment: monitor renal function in patients with severe kidney disease. - Concomitant antibiotics: assess potential for reduced efficacy when combined with broad‑spectrum agents. - Pregnancy and lactation: consult a healthcare professional before use. - Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture and direct sunlight.

Nifuroksazyd Aflofarm may interact with other medicines; awareness helps prevent reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may potentiate bleeding risk. - Other nitrofuran agents: additive toxicity to bone marrow.

Moderate Interactions (Monitor Closely): - Broad‑spectrum antibiotics: possible antagonism reducing antibacterial effect. - Probiotics: may alter gut flora and affect drug activity. - Antidiarrhoeal agents (e.g., loperamide): could prolong exposure to the drug in the intestine. - Immunosuppressants: monitor for heightened infection risk. - Oral contraceptives: theoretical reduction in efficacy, advise additional contraceptive measures.